The effect of intravenous vitamin C on the serum level of phosphorus in hemodialysis patients
Not Applicable
- Conditions
- End stage renal disease.Chronic kidney disease, stage 5
- Registration Number
- IRCT201406118032N3
- Lead Sponsor
- Research Deputy of Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
inclusion criteria: at least 6 months hemodialysis history; serum phosphor level higher than 5.5.
exclusion criteria: history of liver failure; heart failure; respiratory failure and history of vitamin c intake.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum level of phosphor. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical.;Serum calcium level. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical.;Blood Hemoglobin level. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical.;Serum PTH. Timepoint: Baseline and 2 months after. Method of measurement: paraclinical.
- Secondary Outcome Measures
Name Time Method